21
Feb
22
Feb

Dublin

Presented by

IPHA IPHA
BPCI BPCI
NIBRT NIBRT

Event Sponsors

PWC PWC

Agency partners

Intertrade Ireland Intertrade Ireland

Pre-Conference Meeting: The Future of Biopharma Manufacturing

08.00
Registration
09.00
Graham Symcox, MD, PharmaCentaur AG
Overview of Opportunities in Biopharma Development & Manufacturing
09.45
Nigel Darby, Advisor, GE Healthcare Life Sciences
The vendor perspective: The manufacturing facility of the future
10.30
Networking Break
11.00
Aine Hanly, PhD, Vice President Drug Substance Technologies and Site Head, Cambridge, Massachusetts, Amgen
Case study on single use manufacturing: Next generation biomanufacturing at Amgen Singapore Manufacturing (ASM)

Dr Humphrey Moynihan, Research Advisor, Eli Lilly
Case study on continuous manufacturing
12.00
Networking Lunch
13.00
Brendan Hughes, Vice President, Manufacturing Sciences and Technology, BMS
Biomanufacturing at BMS: enabling the immuno-oncology revolution
13.45
Prof Kieran Hodnett, Scientific Director and Principal Investigator SSPC, UL
The research perspective: New frontiers in pharmaceutical synthesis, crystallization and formulation
14.15
Prof Gavin Davey, Head of School of Biochemistry and Immunology, Trinity College Dublin
The research perspective: Advanced biopharmaceutical technologies
14.45
Networking Break
15.00
Addressing the cost of biopharma manufacturing
- Eddie Reilly, VP, Head of Regulatory CMC & Devices, Sanofi
- Dr Ian Jones, CEO, Innopharma
- Michael O’Donnell, Vice President Operations and Site Leader, Shanbally, Co. Cork, BioMarin International
16.00
Dr Lorraine Nolan, Chief Executive, Health Products Regulatory Authority
The Regulator’s Perspective on the future of biopharma manufacturing
Close